82 related articles for article (PubMed ID: 30999005)
1. Differential Expression of HMGA1 and HMGA2 in pituitary neuroendocrine tumors.
Portovedo S; Gaido N; de Almeida Nunes B; Nascimento AG; Rocha A; Magalhães M; Nascimento GC; Pires de Carvalho D; Soares P; Takiya C; Faria MDS; Miranda-Alves L
Mol Cell Endocrinol; 2019 Jun; 490():80-87. PubMed ID: 30999005
[TBL] [Abstract][Full Text] [Related]
2. Identification of cholesterol metabolism-related subtypes in nonfunctioning pituitary neuroendocrine tumors and analysis of immune infiltration.
Feng T; Hou P; Mu S; Fang Y; Li X; Li Z; Wang D; Chen L; Lu L; Lin K; Wang S
Lipids Health Dis; 2023 Aug; 22(1):127. PubMed ID: 37563740
[TBL] [Abstract][Full Text] [Related]
3. Differential expression levels of β-catenin are associated with invasive behavior of both functional and non-functional pituitary neuroendocrine tumor (PitNET).
Taghavi SF; Ghorbani M; Panahi M; Nazem S; Karimi M; Salimi V; Tavakoli-Yaraki M
Mol Biol Rep; 2023 Aug; 50(8):6425-6434. PubMed ID: 37326745
[TBL] [Abstract][Full Text] [Related]
4. Multilineage Pituitary Neuroendocrine Tumors (PitNETs) Expressing PIT1 and SF1.
Asa SL; Mete O; Riddle ND; Perry A
Endocr Pathol; 2023 Sep; 34(3):273-278. PubMed ID: 37268858
[TBL] [Abstract][Full Text] [Related]
5. Erythropoietin-producing hepatocellular receptor B6 is highly expressed in non-functioning pituitary neuroendocrine tumors and its expression correlates with tumor size.
Rubinfeld H; Cohen ZR; Bendavid U; Fichman-Horn S; Levy-Barda A; David C; Melamed P; Shimon I
Mol Biol Rep; 2024 Feb; 51(1):297. PubMed ID: 38341842
[TBL] [Abstract][Full Text] [Related]
6. Clinical and Proteomic-Based Molecular Characterizations of Invasive and Noninvasive Somatotroph PitNETs.
Chen M; Duan L; Sun W; Guo Z; Miao H; Yu N; Yang S; Wang L; Gong F; Yao Y; Zhu H
Neuroendocrinology; 2023; 113(9):971-986. PubMed ID: 37253344
[TBL] [Abstract][Full Text] [Related]
7. HMGA2: a biomarker significantly overexpressed in high-grade ovarian serous carcinoma.
Mahajan A; Liu Z; Gellert L; Zou X; Yang G; Lee P; Yang X; Wei JJ
Mod Pathol; 2010 May; 23(5):673-81. PubMed ID: 20228781
[TBL] [Abstract][Full Text] [Related]
8. [Epidemiology, Genetics and Pathogenesis of Pituitary Neuroendocrine Tumors].
Suzuki K; Tahara S
No Shinkei Geka; 2023 Jul; 51(4):593-606. PubMed ID: 37491056
[TBL] [Abstract][Full Text] [Related]
9. Single-cell transcriptomics reveal distinct immune-infiltrating phenotypes and macrophage-tumor interaction axes among different lineages of pituitary neuroendocrine tumors.
Lin S; Dai Y; Han C; Han T; Zhao L; Wu R; Liu J; Zhang B; Huang N; Liu Y; Lai S; Shi J; Wang Y; Lou M; Xie J; Cheng Y; Tang H; Yao H; Fang H; Zhang Y; Wu X; Shen L; Ye Y; Xue L; Wu ZB
Genome Med; 2024 Apr; 16(1):60. PubMed ID: 38658971
[TBL] [Abstract][Full Text] [Related]
10. Oxidative stress in pituitary neuroendocrine tumors: Affecting the tumor microenvironment and becoming a new target for pituitary neuroendocrine tumor therapy.
Zhou Y; Zhang A; Fang C; Yuan L; Shao A; Xu Y; Zhou D
CNS Neurosci Ther; 2023 Oct; 29(10):2744-2759. PubMed ID: 37341156
[TBL] [Abstract][Full Text] [Related]
11. Aggressive PitNETs and Potential Target Therapies: A Systematic Review of Molecular and Genetic Pathways.
Serioli S; Agostini L; Pietrantoni A; Valeri F; Costanza F; Chiloiro S; Buffoli B; Piazza A; Poliani PL; Peris-Celda M; Iavarone F; Gaudino S; Gessi M; Schinzari G; Mattogno PP; Giampietro A; De Marinis L; Pontecorvi A; Fontanella MM; Lauretti L; Rindi G; Olivi A; Bianchi A; Doglietto F
Int J Mol Sci; 2023 Oct; 24(21):. PubMed ID: 37958702
[TBL] [Abstract][Full Text] [Related]
12. Identification of HMGA2 inhibitors by AlphaScreen-based ultra-high-throughput screening assays.
Su L; Bryan N; Battista S; Freitas J; Garabedian A; D'Alessio F; Romano M; Falanga F; Fusco A; Kos L; Chambers J; Fernandez-Lima F; Chapagain PP; Vasile S; Smith L; Leng F
Sci Rep; 2020 Nov; 10(1):18850. PubMed ID: 33139812
[TBL] [Abstract][Full Text] [Related]
13. Derepression of HMGA2 gene expression in retinoblastoma is associated with cell proliferation.
Chau KY; Manfioletti G; Cheung-Chau KW; Fusco A; Dhomen N; Sowden JC; Sasabe T; Mukai S; Ono SJ
Mol Med; 2003; 9(5-8):154-65. PubMed ID: 14571323
[TBL] [Abstract][Full Text] [Related]
14. Transcriptome Analysis Reveals Distinct Patterns Between the Invasive and Noninvasive Pituitary Neuroendocrine Tumors.
Jotanovic J; Tebani A; Hekmati N; Sivertsson Å; Lindskog C; Uhlèn M; Gudjonsson O; Tsatsaris E; Engström BE; Wikström J; Pontén F; Casar-Borota O
J Endocr Soc; 2024 Mar; 8(5):bvae040. PubMed ID: 38505563
[TBL] [Abstract][Full Text] [Related]
15. The Chromatin Regulator HMGA1a Undergoes Phase Separation in the Nucleus.
Zhu H; Narita M; Joseph JA; Krainer G; Arter WE; Olan I; Saar KL; Ermann N; Espinosa JR; Shen Y; Kuri MA; Qi R; Welsh TJ; Collepardo-Guevara R; Narita M; Knowles TPJ
Chembiochem; 2023 Jan; 24(1):e202200450. PubMed ID: 36336658
[TBL] [Abstract][Full Text] [Related]
16. From Benign to Malignant: The Arrival of Pituitary Neuroendocrine Tumors (PitNETs).
Meagher T
J Insur Med; 2023 Jul; 50(2):154-156. PubMed ID: 38358922
[TBL] [Abstract][Full Text] [Related]
17. High Mobility Group A proteins in esophageal carcinomas.
Palumbo Júnior A; Da Costa NM; Esposito F; Fusco A; Pinto LF
Cell Cycle; 2016 Sep; 15(18):2410-3. PubMed ID: 27484584
[TBL] [Abstract][Full Text] [Related]
18. Emerging Role of USP8, HMGA, and Non-Coding RNAs in Pituitary Tumorigenesis.
D'Angelo D; De Martino M; Arra C; Fusco A
Cancers (Basel); 2019 Sep; 11(9):. PubMed ID: 31487906
[TBL] [Abstract][Full Text] [Related]
19. Overview of omics biomarkers in pituitary neuroendocrine tumors to design future diagnosis and treatment strategies.
Aydin B; Caliskan A; Arga KY
EPMA J; 2021 Sep; 12(3):383-401. PubMed ID: 34567287
[TBL] [Abstract][Full Text] [Related]
20. Trouillas's Grading and Post-Surgical Tumor Residue Assessment in Pituitary Adenomas: The Importance of the Multidisciplinary Approach.
Calandrelli R; Mattogno PP; Chiloiro S; Gessi M; D'Apolito G; Tartaglione T; Giampietro A; Bianchi A; Doglietto F; Lauretti L; Gaudino S
Diagnostics (Basel); 2024 Jan; 14(3):. PubMed ID: 38337790
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
